U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn) AND CFTR-related disorder

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jan 23, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001158873.14

Allele description [Variation Report for NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)]

NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)
HGVS:
  • NC_000007.14:g.117642528G>A
  • NG_016465.4:g.181745G>A
  • NM_000492.4:c.3808G>AMANE SELECT
  • NP_000483.3:p.Asp1270Asn
  • NP_000483.3:p.Asp1270Asn
  • LRG_663t1:c.3808G>A
  • LRG_663:g.181745G>A
  • LRG_663p1:p.Asp1270Asn
  • NC_000007.13:g.117282582G>A
  • NM_000492.3:c.3808G>A
  • P13569:p.Asp1270Asn
Protein change:
D1270N; ASP1270ASN
Links:
Genetic Testing Registry (GTR): GTR000257096; UniProtKB: P13569#VAR_000260; OMIM: 602421.0060; dbSNP: rs11971167
NCBI 1000 Genomes Browser:
rs11971167
Molecular consequence:
  • NM_000492.4:c.3808G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
CFTR-related disorder (CFTR-RD)
Synonyms:
CFTR-related disorders; CFTR-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001320536Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Likely benign
(Apr 27, 2017)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV004114204PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 23, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

[R74W;R1070W;D1270N]: a new complex allele responsible for cystic fibrosis.

de Prada Merino A, Bütschi FN, Bouchardy I, Beckmann JS, Morris MA, Hafen GM, Fellmann F.

J Cyst Fibros. 2010 Dec;9(6):447-9. doi: 10.1016/j.jcf.2010.08.014. Epub 2010 Sep 28.

PubMed [citation]
PMID:
20880762

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.

Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, Hong JS, Pollard HB, Guggino WB, Balch WE, Skach WR, Cutting GR, Frizzell RA, Sheppard DN, Cyr DM, Sorscher EJ, Brodsky JL, Lukacs GL.

Mol Biol Cell. 2016 Feb 1;27(3):424-33. doi: 10.1091/mbc.E14-04-0935.

PubMed [citation]
PMID:
26823392
PMCID:
PMC4751594
See all PubMed Citations (7)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV001320536.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From PreventionGenetics, part of Exact Sciences, SCV004114204.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The CFTR c.3808G>A variant is predicted to result in the amino acid substitution p.Asp1270Asn. This variant has been reported in patients with congenital bilateral absence of the vas deferens (Anguiano et al. 1992. PubMed ID: 1545465; Oates et al. 1993. PubMed ID: 8343799; Padoa et al. 1999. PubMed ID: 9950364; Chamayou et al. 2020. PubMed ID: 32357917), but has also been observed in the homozygous or compound heterozygous state in asymptomatic individuals (Terlizzi et al. 2017. PubMed ID: 27738188; Chamayou et al. 2020. PubMed ID: 32357917). The p.Asp1270Asn variant resulted in minimal disruption to CFTR processing in HeLa and FRT cells, suggesting normal CFTR maturation (Fanen et al. 1999. PubMed ID: 10386624; Sosnay et al 2013. PubMed ID: 23974870; Van Goor et al. 2014. PubMed ID: 23891399). In FRT cells, the p.Asp1270Asn variant retained nearly half of wild-type CFTR chloride channel transport function, which was restored to wild-type levels with ivacaftor, suggesting a mild defect in channel conductance (Sosnay et al 2013. PubMed ID: 23974870; Van Goor et al. 2014. PubMed ID: 23891399). Consistent with this, in HeLa cells, the p.Asp1270Asn variant impaired cAMP-responsive anion conductance of CFTR (Fanen et al. 1999. PubMed ID: 10386624). The p.Asp1270Asn variant is documented in 57 patients in the CFTR2 database with an average sweat chloride concentration of 57 mEq/L, compared to an average of 96 mEq/L for all patients in CFTR2 with two CF-causing variants (cftr2.org). This variant is reported in up to ~1.4% of alleles in individuals of African descent in gnomAD, including three homozygous individuals of unknown phenotype. In ClinVar, this variant has conflicting interpretations of pathogenicity ranging from benign to pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/7164). In summary, due to conflicting genetic and functional evidence, the clinical significance of the p.Asp1270Asn variant is uncertain. Of note, the p.Arg74Trp and p.Asp1270Asn variants have been reported in linkage (on the same allele) and are collectively referred to as p.[Arg74Trp;Asp1270Asn]. Variant phasing information in gnomAD indicates that the p.Arg74Trp and p.Asp1270Asn variants likely occur in cis within the African, Latino/Admixed American and European (non-Finnish) subpopulations, but may rarely occur independently of each other. Consistent with this, one study observed that 94% of individuals carrying the p.Asp1270Asn variant also carried the p.Arg74Trp variant (Sugarman et al. 2004. PubMed ID: 15371903). The p.[Arg74Trp; Asp1270Asn] complex allele has been reported in compound heterozygous individuals with CBAVD and obstructive bronchitis (Claustres et al. 2004. PubMed ID: 15287992; Terlizzi et al. 2017. PubMed ID: 27738188; Chamayou et al. 2020. PubMed ID: 32357917), but has also been observed in the compound heterozygous state in asymptomatic individuals (Verlingue et al. 1993. PubMed ID: 7513889; Claustres et al. 2004. PubMed ID: 15287992; Terlizzi et al. 2017. PubMed ID: 27738188). In HeLa cells, the p.[Arg74Trp; Asp1270Asn] variant did not affect CFTR processing but did result in impaired cAMP-responsive anion conductance (Fanen et al. 1999. PubMed ID: 10386624). The authors suggest that both variants together may lead to a synergistic effect to further impair CFTR function than either variant in isolation (Fanen et al. 1999. PubMed ID: 10386624; Claustres et al. 2004. PubMed ID: 15287992). In addition, Sosnay et al. in a comprehensive study of CFTR variants classified these variants as “indeterminate” (Sosnay et al 2013. PubMed ID: 23974870). In ClinVar, the complex allele p.[Arg74Trp; Asp1270Asn] is interpreted as uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/977735). In summary, due to the conflicting genetic and functional evidence, the clinical significance of the complex p.[R74W; D1270N] variant is also uncertain.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024